G
Gunnar Bjune
Researcher at University of Oslo
Publications - 149
Citations - 9245
Gunnar Bjune is an academic researcher from University of Oslo. The author has contributed to research in topics: Tuberculosis & Population. The author has an hindex of 48, co-authored 149 publications receiving 8627 citations. Previous affiliations of Gunnar Bjune include Stavanger University Hospital & University of Bergen.
Papers
More filters
Journal ArticleDOI
A systematic review of delay in the diagnosis and treatment of tuberculosis
TL;DR: The core problem in delay of diagnosis and treatment seemed to be a vicious cycle of repeated visits at the same healthcare level, resulting in nonspecific antibiotic treatment and failure to access specialized TB services.
Journal ArticleDOI
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.
Gunnar Bjune,Høiby Ea,Grønnesby Jk,Ø Arnesen,J.H Fredriksen,A-K Lindbak,Hanne Nøkleby,E. Rosenqvist,L.K Solberg,O Closs,L O Frøholm,Lystad A,L.S Bakketeig,B Hareide,Alfred Halstensen,E Holten,J Eng +16 more
TL;DR: It is suggested that, although the vaccine conferred protection against group B meningococcal disease, the effect was insufficient to justify a public vaccination programme.
Journal ArticleDOI
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.
Rogelio Hernández-Pando,Mangalakumari Jeyanathan,Getahun Mengistu,Diana Aguilar,Héctor Fabio Bermúdez Orozco,Morten Harboe,Graham A. W. Rook,Gunnar Bjune +7 more
TL;DR: Findings contradict the dominant view that latent organisms exist in old classic tuberculous lesions, and have important implications for strategies aimed at the elimination of latent and persistent bacilli.
Journal ArticleDOI
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population
Dominique A. Caugant,Ernst Arne Høiby,P Magnus,O Scheel,T Hoel,Gunnar Bjune,E Wedege,J Eng,L O Frøholm +8 more
TL;DR: Age between 15 and 24, male sex, and active and passive smoking were found to be independently associated with meningococcal carriage in logistic regression analyses and carriage eradication among close contacts of persons with systemic disease is unlikely to have a significant impact on the overall epidemiological situation.
Journal Article
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.
J.H Fredriksen,Einar Rosenqvist,E Wedege,K Bryn,Gunnar Bjune,L O Frøholm,Lindbak Ak,Møgster B,E. Namork,Rye U +9 more
TL;DR: The vaccine against serogroup B meningococcal disease has been prepared from a B:15:P1.7,16 mening bacteria by fermentor growth and extraction of the bacteria with the detergent deoxycholate and was highly immunogenic in mice and humans.